Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Disease area: Airway diseases, Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Makaryants, L. Lepekha, E. Shmelev, I. Sivokozov (Moscow, Russian Federation). Administration of lasolvan in the treatment for exogenic allergic alveolitis (EAA). Eur Respir J 2012; 40: Suppl. 56, 400

Member's Comments

No comment yet.

Related content which might interest you: High-dose inhalation corticosteroids in conjunction with plasmapheresis in the treatment of patients with acute variant of exogenic allergic alveolitis (EAA) Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Use of acetylcysteinein the treatment of patients with exogenic allergic alveolitis (EAA) Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Systemic steroid use in children with allergic (IgE-mediated) asthma receiving omalizumab Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 The effects of two weeks of repeated low-dose allergen exposure on sputum eosinophilic and neutrophilic inflammation in atopic asthma: protection by inhaled steroids? Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001 Effects of corticosteroid and montelukast treatment in inflammation in guinea pigs with chronic allergic inflammation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Sarcoidosis on the internet Source: Annual Congress 2007 - Medical education and patient education including e-learning Year: 2007 Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Hypersensitivity pneumonitis caused by occupational exposure to phytase Source: Eur Respir J 2009; 33: 1507-1509 Year: 2009 Clinical efficacy of leukotriene antagonist in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005 Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 121s Year: 2006 Effect of desloratadine on patients suffer from allergic rhinitis and bronchial hyperreactivity Source: Eur Respir J 2003; 22: Suppl. 45, 135s Year: 2003 Single-dose desloratadine and montelukast and allergen-induced late airway responses Source: Eur Respir J 2009; 33: 1302-1308 Year: 2009 Intranasal and inhaled corticosteroids in allergic rhinitis and asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Budesonide and loratadine in the treatment of allergic rhinitis in children Source: Eur Respir J 2003; 22: Suppl. 45, 134s Year: 2003 Antihistamines (cetirizine and loratadine) and antileukotriene (montelukast) in the prevention of allergic rhinitis symptoms Source: Eur Respir J 2003; 22: Suppl. 45, 103s Year: 2003 Does treatment of allergic rhinitis with intranasal steroids improve asthma control Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 The efficacy of desloratadine in the treatment of allergic rhinitis Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004 Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab Source: Eur Respir J 2003; 22: Suppl. 45, 203s Year: 2003 The role of omalizumab or rhuMAb-E25 in the treatment of allergic rhinitis Source: Eur Respir J 2004; 24: 330 Year: 2004